Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Canada Creating Genomics Innovation Network

Published: Wednesday, June 04, 2014
Last Updated: Tuesday, June 10, 2014
Bookmark and Share
Network will create a mechanism for cross-country collaboration, providing access to the highest quality genomic technologies and advice.

Genome Canada have released a request for applications for membership in the Genomics Innovation Network (GIN) and core operations support funds. 

“The goal of this network will be to facilitate an environment that allows innovation centres across Canada to collaborate and harness their collective power for the advancement of genomics research,” said Dr. Pierre Meulien, Genome Canada’s President and CEO.

The vision is for each network member, to be designated as a Node, to provide researchers access to high throughput genomic technologies, such as DNA sequencing, RNA expression, protein identification and quantitation, and metabolomics, as well as new method and protocol development, data analysis and bioinformatics. Nodes will also assist researchers in the development of research proposals by providing advice on appropriate technologies, study design, data analysis and bioinformatics that improve the quality of the research. 

The competition will provide a total of up to $16 million to the successful applicants. This support is provided from the $165 million provided to Genome Canada from the Government of Canada in Budget 2013. Up to $2 million is available for each Node to support core operations, with a requirement that they secure an equal amount of co-funding from other partners. Facilities that are successful in applying for membership, and have been provided with core operating funds, can then apply for technology development funds that Genome Canada will supply through a subsequent competition to GIN members.

Applicants must register with their regional Genome Centre by August 1, 2014, with applications submitted September 15, 2014 and award notices issued in December 2014.

Genome Canada funds and manages large-scale, milestone-driven genomics research projects in the areas of agriculture, energy, environment, fisheries, forestry, health, and mining. Genome Canada’s mission includes a commitment to provide researchers across Canada access to leading-edge technology in all genomics-related fields.

“Canada is a global leader in genomics, and the Genomics Innovation Network will ensure Canadians reap the full benefit of our investments. This is about ensuring that the latest developments in this fast moving field will rapidly make their way into society, whether by improving the health of Canadians, creating new companies in advanced manufacturing, or protecting our vast natural resources through responsible and efficient extraction and remediation technologies,” said Dr. Meulien.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Canada’s New Genomics Innovation Network Unveiled
10 “Nodes” located in BC, Alberta, Ontario and Quebec to provide leading-edge technologies to researchers across Canada.
Wednesday, April 01, 2015
Scientific News
New Treatment for Pancreatic Cancer
Researchers at Purdue University have shown how controlling cholesterol metabolism in pancreatic cancer cells reduces metastasis.
Plasma Biomarkers for Breast Cancer Diagnosis
Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions.
How Different People Respond To Aspirin
Study findings could be used to help identify those who would benefit most from aspirin use.
Altered Metabolism of Four Compounds Drives Glioblastoma Growth
Findings suggest new ways to treat the malignancy, slow its progression and reveal its extent more precisely.
A Metabolic Twist that Drives Cancer Survival
A novel metabolic pathway that helps cancer cells thrive in conditions that are lethal to normal cells has been identified.
Liver-On-Chip Tracks Dynamics of Cellular Function
Hebrew University’s liver-on-chip platform is uniquely able to monitor metabolic changes indicating mitochondrial damage occurring at drug concentrations previously regarded as safe.
Living Off the Fat of the Land
Do cancer cells synthesize the parts for new cells or scavenge them from the environment?
Liver Disease, Obesity Linked
Kanazawa University researchers find similarities in the impeded signalling between central insulin activity and glucose production in the liver for both obese mice and mice that have had the vagus nerve removed.
Decoding Ties Between Vascular Disease, Alzheimer’s
NIH consortium uses big data, team science to uncover complex interplay of factors.
Gene Identified that May Worsen Cancer Outcome
Some patients with breast cancer, lung cancer and leukaemia seem to fare poorly after treatment because of the effects of a particular gene, a new study finds.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!